237 related articles for article (PubMed ID: 19035310)
1. Cytotoxicity of a series of ferrocene-containing beta-diketones.
Swarts JC; Vosloo TG; Cronje SJ; Du Plessis WC; Van Rensburg CE; Kreft E; Van Lier JE
Anticancer Res; 2008; 28(5A):2781-4. PubMed ID: 19035310
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of ruthenocene-containing β-diketones.
Kemp KC; Nell MJ; VAN Rensburg CE; Swarts JC
Anticancer Res; 2012 Jul; 32(7):2915-8. PubMed ID: 22753755
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic activity of a series of ferrocene-containing alcohols.
Shago RF; Swarts JC; Kreft E; Van Rensburg CE
Anticancer Res; 2007; 27(5A):3431-3. PubMed ID: 17970091
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of ferrocenyl-ethynyl phosphine metal complexes of gold and platinum.
Fourie E; Erasmus E; Swarts JC; Jakob A; Lang H; Joone GK; VAN Rensburg CE
Anticancer Res; 2011 Mar; 31(3):825-9. PubMed ID: 21498702
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of a series of water-soluble mixed valent diruthenium tetracarboxylates.
Van Rensburg CE; Kreft E; Swarts JC; Dalrymple SR; MacDonald DM; Cooke MW; Aquino MA
Anticancer Res; 2002; 22(2A):889-92. PubMed ID: 12014667
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of hydrophylic silver carboxylato complexes.
Fourie E; Erasmus E; Swarts JC; Tuchscherer A; Jakob A; Lang H; Joone GK; Van Rensburg CE
Anticancer Res; 2012 Feb; 32(2):519-22. PubMed ID: 22287740
[TBL] [Abstract][Full Text] [Related]
7. Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines.
Kelland LR; Murrer BA; Abel G; Giandomenico CM; Mistry P; Harrap KR
Cancer Res; 1992 Feb; 52(4):822-8. PubMed ID: 1737343
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, electrochemical studies and antitumor activity of some new chalcone analogues containing ferrocenyl pyrazole moiety.
Ratković Z; Juranić ZD; Stanojković T; Manojlović D; Vukićević RD; Radulović N; Joksović MD
Bioorg Chem; 2010 Feb; 38(1):26-32. PubMed ID: 19846191
[TBL] [Abstract][Full Text] [Related]
9. Superior cytotoxicity of hydrophylic gold carboxylato complexes over hydrophylic silver carboxylates.
Langner EH; Swarts JC; Tuchscherer A; Lang H; Joone GK; VAN Rensburg CE
Anticancer Res; 2012 Jul; 32(7):2697-701. PubMed ID: 22753728
[TBL] [Abstract][Full Text] [Related]
10. The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif.
Hillard EA; Pigeon P; Vessières A; Amatore C; Jaouen G
Dalton Trans; 2007 Nov; (43):5073-81. PubMed ID: 17992292
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, cytotoxicity, and COMPARE analysis of ferrocene and [3]ferrocenophane tetrasubstituted olefin derivatives against human cancer cells.
Görmen M; Pigeon P; Top S; Hillard EA; Huché M; Hartinger CG; de Montigny F; Plamont MA; Vessières A; Jaouen G
ChemMedChem; 2010 Dec; 5(12):2039-50. PubMed ID: 20949584
[TBL] [Abstract][Full Text] [Related]
12. Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell lines.
Buriez O; Heldt JM; Labbé E; Vessières A; Jaouen G; Amatore C
Chemistry; 2008; 14(27):8195-203. PubMed ID: 18668496
[TBL] [Abstract][Full Text] [Related]
13. Polyaspartamides as water-soluble drug carriers. Part 1: Antineoplastic activity of ferrocene-containing polyaspartamide conjugates.
Swarts JC; Swarts DM; Maree DM; Neuse EW; La Madeleine C; Van Lier JE
Anticancer Res; 2001; 21(3B):2033-7. PubMed ID: 11497294
[TBL] [Abstract][Full Text] [Related]
14. Relationship between electrochemical potentials and substitution reaction rates of ferrocene-containing β-diketonato rhodium(I) complexes; cytotoxicity of [Rh(FcCOCHCOPh)(cod)].
Conradie J; Swarts JC
Dalton Trans; 2011 Jun; 40(22):5844-51. PubMed ID: 21423964
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.
Zsoldos-Mády V; Csámpai A; Szabó R; Mészáros-Alapi E; Pásztor J; Hudecz F; Sohár P
ChemMedChem; 2006 Oct; 1(10):1119-25. PubMed ID: 16944543
[TBL] [Abstract][Full Text] [Related]
16. Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds.
Zekri O; Hillard EA; Top S; Vessières A; Pigeon P; Plamont MA; Huché M; Boutamine S; McGlinchey MJ; Müller-Bunz H; Jaouen G
Dalton Trans; 2009 Jun; (22):4318-26. PubMed ID: 19662309
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
[TBL] [Abstract][Full Text] [Related]
18. Antiplasmodial activity of ferrocenyl chalcones: investigations into the role of ferrocene.
Wu X; Tiekink ER; Kostetski I; Kocherginsky N; Tan AL; Khoo SB; Wilairat P; Go ML
Eur J Pharm Sci; 2006 Feb; 27(2-3):175-87. PubMed ID: 16269240
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and antitumor activity of new type binuclear platinum(II) complexes.
Zhang J; Liu L; Gong Y; Zheng X; Yang M; Cui J; Shen S
Eur J Med Chem; 2009 May; 44(5):2322-7. PubMed ID: 18524422
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, oxidation chemistry and cytotoxicity studies on ferrocene derivatives of diethylstilbestrol.
Tan YL; Pigeon P; Hillard EA; Top S; Plamont MA; Vessières A; McGlinchey MJ; Müller-Bunz H; Jaouen G
Dalton Trans; 2009 Dec; (48):10871-81. PubMed ID: 20023917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
